Takeda Pharmaceutical Co (MEX:TAK) Revenue : MXN549,587 Mil (TTM As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Revenue?

Takeda Pharmaceutical Co's revenue for the three months ended in Sep. 2024 was MXN161,986 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was MXN549,587 Mil. Takeda Pharmaceutical Co's Revenue per Share for the three months ended in Sep. 2024 was MXN50.32. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was MXN171.91.

During the past 12 months, the average Revenue per Share Growth Rate of Takeda Pharmaceutical Co was 7.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Takeda Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 11.60% per year. The lowest was -3.30% per year. And the median was 4.05% per year.

Takeda Pharmaceutical Co Revenue Historical Data

The historical data trend for Takeda Pharmaceutical Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Revenue Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Revenue

Get a 7-Day Free Trial

716,761.51

601,352.50

599,291.93

543,116.53

472,321.07

Takeda Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Revenue	Get a 7-Day Free Trial															122,895.33	130,999.79	116,410.71	140,190.68	161,985.96

Competitive Comparison of Takeda Pharmaceutical Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Revenue distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Revenue falls into.

Takeda Pharmaceutical Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN549,587 Mil.

Takeda Pharmaceutical Co (MEX:TAK) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Takeda Pharmaceutical Co Revenue Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA 4502:Japan 0A87:UK TKDA:Germany TAKP34:Brazil TKD:Austria

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.